Walgreens Boots Alliance (NASDAQ:WBA) Issues FY 2024 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of 2.800-2.950 for the period, compared to the consensus earnings per share estimate of 3.200. The company issued revenue guidance of -. Walgreens Boots Alliance also updated its FY24 guidance to $2.80-$2.95 EPS.

Walgreens Boots Alliance Price Performance

WBA opened at $12.10 on Friday. Walgreens Boots Alliance has a twelve month low of $11.68 and a twelve month high of $31.32. The company has a quick ratio of 0.32, a current ratio of 0.65 and a debt-to-equity ratio of 0.49. The company has a fifty day simple moving average of $16.49 and a 200 day simple moving average of $20.17.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing the consensus estimate of $0.67 by ($0.04). Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The business had revenue of $36.40 billion for the quarter, compared to analyst estimates of $35.94 billion. During the same quarter in the prior year, the business earned $1.00 earnings per share. The firm’s revenue was up 2.8% on a year-over-year basis. As a group, sell-side analysts expect that Walgreens Boots Alliance will post 2.94 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st were given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.27%. The ex-dividend date was Monday, May 20th. Walgreens Boots Alliance’s payout ratio is -14.84%.

Wall Street Analyst Weigh In

WBA has been the topic of several recent analyst reports. Evercore ISI cut their price target on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an in-line rating on the stock in a report on Friday. Truist Financial cut their target price on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a hold rating on the stock in a research note on Friday. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a hold rating on the stock in a research report on Wednesday, April 3rd. Barclays dropped their target price on shares of Walgreens Boots Alliance from $21.00 to $19.00 and set an underweight rating on the stock in a report on Monday, June 24th. Finally, SVB Leerink dropped their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a market perform rating on the stock in a research note on Monday, March 18th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Walgreens Boots Alliance currently has a consensus rating of Hold and an average price target of $20.64.

Insiders Place Their Bets

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari acquired 3,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, April 11th. The stock was bought at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the transaction, the director now owns 3,000 shares in the company, valued at approximately $54,150. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, Director Inderpal S. Bhandari bought 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 11th. The shares were acquired at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the acquisition, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Manmohan Mahajan bought 6,000 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, April 2nd. The shares were bought at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the acquisition, the chief financial officer now owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is owned by company insiders.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.